Bone Marrow Biopsy Complications: Causes and Management

·

Share

Serious bone marrow biopsy complications are uncommon. Most people have nothing worse than a sore hip and a small bruise for a few days. When problems do occur, they are usually bleeding at the needle site, infection, or pain from nearby nerves, and nearly all can be spotted early and treated simply. This guide covers why complications happen, who is at higher risk, what warning signs to watch for, how doctors manage them, and what has changed in recent years to make the procedure safer.

What Happens During a Bone Marrow Biopsy?

A bone marrow biopsy is one of the core diagnostic tests in hematology. A doctor numbs the skin and the surface of the bone, then uses a hollow needle to remove a small amount of bone marrow tissue. The usual site is the back of the pelvic bone, called the posterior iliac crest.

Two samples are normally taken. The aspirate is liquid marrow drawn into a syringe, used to look at individual cells. The trephine (core) biopsy is a small cylinder of bone and marrow that shows how the marrow is organized and how full of cells it is. If you want a step-by-step walkthrough, see our guide on how a bone marrow biopsy is performed.

The test helps diagnose and monitor many blood disorders, including leukemia, lymphoma, myeloma, aplastic anemia, and unexplained low blood counts.

Causes and Risk Factors of Bone Marrow Biopsy Complications

Why complications happen

Almost every complication comes from the mechanics of the procedure: a needle passing through skin, soft tissue, and bone. Bone marrow is richly supplied with blood vessels, so a little oozing is expected. Problems arise when bleeding doesn’t stop, when bacteria enter the puncture, or when the needle strays toward nearby structures.

Who is at higher risk

  • People with bleeding disorders such as hemophilia or von Willebrand disease, or with severe clotting abnormalities.
  • People taking blood thinners, including warfarin, the newer oral anticoagulants, and antiplatelet drugs like clopidogrel.
  • People with very low platelets, although many biopsies are still done safely in this setting with extra pressure afterward.
  • People with weakened immunity, for example from chemotherapy or very low neutrophil counts, who are more vulnerable to infection.
  • People with obesity or unusual pelvic anatomy, where landmarks are harder to feel and the needle path is less predictable.
  • People with thin or fragile bone, such as those with osteoporosis or bone involved by cancer.

Types of Complications and Their Warning Signs

The table below summarizes the main complications, how often they tend to occur, and what they look like.

Complication How common Typical signs
Local pain and bruising Very common, usually mild Aching at the hip for a few days; small bruise
Prolonged oozing Occasional Dressing soaks through; blood keeps seeping after pressure
Hematoma (collection of blood) Uncommon Growing swelling, firm lump, worsening pain
Retroperitoneal bleeding Rare Deep back, flank, or groin pain; dizziness; falling blood pressure
Infection Rare Redness, warmth, pus, or fever days after the test
Nerve irritation Rare Numbness, tingling, or shooting pain in the buttock or thigh
Needle breakage or bone fracture Very rare Recognized by the operator during the procedure or on imaging

Aspiration from the breastbone (sternum), which is now used much less often, carries its own rare but serious risk: the needle can pass through the thin bone into the chest. That is one reason the hip is the preferred site in adults.

How Complications Are Diagnosed

Most complications are diagnosed with a simple look and feel of the biopsy site. The doctor checks for swelling, tenderness, redness, and discharge, and asks about the timing and character of the pain.

When something deeper is suspected, further tests help:

  • Ultrasound to confirm a hematoma near the surface.
  • CT scan to look for bleeding behind the abdominal lining, in the space called the retroperitoneum.
  • Complete blood count to see whether hemoglobin has dropped from blood loss.
  • Clotting tests to check for an unrecognized bleeding tendency.
  • Inflammatory markers and wound swabs when infection is a concern.

Treatment and Management Strategies

Prevention comes first

The best management starts before the needle goes in. In my practice, I review medications, recent blood counts, and clotting results for every patient. Blood thinners are sometimes paused for a set period, but only after weighing the risk of a clot against the risk of bleeding. Platelet transfusion beforehand is reserved for selected patients rather than used routinely.

Managing bleeding

Firm pressure on the site for several minutes, followed by lying on your back for a short time, controls most oozing. A hematoma under the skin usually settles on its own with rest, ice packs, and simple pain relief. Deep bleeding is managed in hospital with monitoring, correction of any clotting problem, blood transfusion if needed, and, rarely, a procedure to stop the bleeding vessel.

Managing infection

A superficial wound infection is treated with antibiotics, chosen according to the bacteria found where possible. Deeper infection involving bone is rare but needs prompt specialist care and a longer antibiotic course.

Managing pain

Acetaminophen (paracetamol) is the usual first choice. Anti-inflammatory drugs such as ibuprofen work well but may be avoided in people with low platelets or bleeding risk. Persistent nerve-type pain is assessed separately and usually improves over weeks.

Recent Insights Into Safer Biopsies

Several practical developments have improved the experience and safety of the test:

  • Powered drill devices can collect a core sample more quickly than a manual needle, which many patients find shortens the uncomfortable part of the procedure.
  • Image guidance with CT or ultrasound is increasingly used for patients with difficult anatomy, allowing more precise needle placement.
  • Structured safety checklists for medications, platelet counts, and clotting results reduce avoidable bleeding.
  • Blood-based testing, such as flow cytometry and molecular tests on peripheral blood, can sometimes track a known hematological condition and reduce how often repeat biopsies are needed. These tests complement the marrow biopsy; they do not yet replace it for most initial diagnoses.

When to See a Doctor

Keep the dressing on and the site dry for about 24 hours. Contact your care team or seek urgent care if you notice:

  • Bleeding that soaks through the dressing and doesn’t stop with 10 minutes of firm pressure.
  • Swelling that keeps growing, or pain that gets worse instead of better after the first two days.
  • Fever, chills, redness spreading around the site, or pus.
  • Severe back, flank, or groin pain, especially with lightheadedness or a racing heart.
  • New numbness or weakness in the leg.

Frequently Asked Questions

How long does pain last after a bone marrow biopsy?

Most people feel a dull ache at the hip for two to three days, sometimes up to a week. It usually responds well to acetaminophen. Pain that worsens after the first couple of days should be checked.

Can I have a bone marrow biopsy if my platelets are low?

Often, yes. The hip is a compressible site, so bleeding can usually be controlled with firm pressure. Your hematologist will decide whether a platelet transfusion or other precautions are needed based on your count and overall risk.

Do I need to stop my blood thinner before the test?

Sometimes, but never stop it on your own. The decision depends on why you take it and how high your clot risk is. Your doctor will give you specific instructions on whether and when to pause and restart it.

Is infection after a bone marrow biopsy serious?

Infection is rare because the procedure is done with sterile technique. Most infections are confined to the skin and clear with antibiotics. People with weakened immunity should report any fever promptly, since it can signal a more serious infection.

Written by
Blood Disorders, Bone Marrow Biology, Haematology
Contact [email protected] dskrausemdphd Website YaleMarch 23, 2020 Hematopoietic stem/progenitor cell fate specification in health and disease Diane Krause is a physician scientist and international leader in studies of adult stem cells and leukemia. Her research laboratory has made major discoveries regarding the transcriptional regulation of hematopoiesis with an emphasis on megakaryocyte fate specification and maturation as well as platelet function….
View Full Profile →
Web Admin Avatar